Polymersome-based nanomedicine for combined cancer therapy

Aidin Mohammadi Zonouz1,2, Mehrshad Ebrahimpour2, Kimia Zibaei2

  • 1Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.

Drug delivery
|December 22, 2025
PubMed
Resumen

Polymersomes offer a promising platform for cancer combination therapy, enabling simultaneous delivery of multiple treatments. This nanomedicine approach enhances treatment efficacy and precision while minimizing side effects for improved patient outcomes.